Frontlines in geriatrics: Polypharmacy, the key revisions of the 2025 guidelines for medical treatment and its safety in the elderly
Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics · 25.04.2026 · 63 (2) · 79-85
DOI: 10.3143/geriatrics.63.79 ↗Kurz gefasst
Leitlinie in der Zeitschrift Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics, erschienen am 25.04.2026. Verfasst von 太郎 小島. Die Arbeit nennt 15 Literaturangaben.
Themen: Medikationssicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
小島, 太. (2026). Frontlines in geriatrics: Polypharmacy, the key revisions of the 2025 guidelines for medical treatment and its safety in the elderly. Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics, 63(2), 79-85. https://doi.org/10.3143/geriatrics.63.79
Vancouver
小島 太. Frontlines in geriatrics: Polypharmacy, the key revisions of the 2025 guidelines for medical treatment and its safety in the elderly. Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics. 2026;63(2):79-85. doi:10.3143/geriatrics.63.79
BibTeX
@article{2026,
author = {小島, 太郎},
title = {Frontlines in geriatrics: Polypharmacy, the key revisions of the 2025 guidelines for medical treatment and its safety in the elderly},
journal = {Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics},
year = {2026},
volume = {63},
number = {2},
pages = {79--85},
doi = {10.3143/geriatrics.63.79}
}
EUVIMED